Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related CPHD
Morning Market Gainers
US Stock Futures Rise Ahead Of Earnings, Economic Data
Related ABT
Jim Chanos, Kyle Bass Rip Oil And Pharma At SALT 2015
Earnings Beat Propels Abbott Laboratories To New All-Time High
Abbott Labs' Profit Margins Skyrocket And So Does Its Return On Equity (Seeking Alpha)

Analysts at Piper Jaffray downgraded Cepheid (NASDAQ: CPHD) from “overweight” to “neutral.” Cepheid's shares closed at $34.09 yesterday. Cepheid's trailing-twelve-month ROE is -12.52%.

Analysts at Deutsche Bank downgraded Abbott Laboratories (NYSE: ABT) from “buy” to “hold.” Abbott's shares closed at $33.27 yesterday. Abbott's PEG ratio is 0.51.

Analysts at Goldman Sachs downgraded Wells Fargo & Company (NYSE: WFC) from “buy” to “neutral.” Wells Fargo's shares closed at $34.76 yesterday. Wells Fargo's trailing-twelve-month profit margin is 23.18%.

Raymond James downgraded First Solar (NASDAQ: FSLR) from “market perform” to “underperform.” First Solar's shares closed at $34.41 yesterday. First Solar's trailing-twelve-month ROA is 2.17%.

Latest Ratings for CPHD

DateFirmActionFromTo
Apr 2015JMP SecuritiesMaintainsMarket Outperform
Dec 2014Bank of AmericaUpgradesNeutralBuy
Dec 2014CitigroupMaintainsBuy

View More Analyst Ratings for CPHD
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (CPHD + ABT)

Around the Web, We're Loving...